ARK Investment Management LLC - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for CRISPR Therapeutics AG (CRSP)

Filing Manager: ARK Investment Management LLC
Reporting Manager: ARK Investment Management LLC
Security: CRISPR Therapeutics AG Common Stock
Symbol: CRSP
Shares outstanding: 85.4M shares
Disclosed Ownership: 8.97M shares
Ownership: 10.5%
Form type: SCHEDULE 13G/A
Date filed: 2/14/2025, 11:23 AM
Date of event: Dec 31, 2024
Previous filing: Jan 10, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
ARK Investment Management LLC	10.51%	8.97M	8.44M	193K	/s/ Kellen Carter	Kellen Carter, Chief Compliance Officer